The Heart Pump Device Market was valued at USD 2.99 billion in 2024, and is projected to reach USD 6.39 billion by 2030, rising at a CAGR of 13.60%. The growing prevalence of coronary artery disease, ischemic heart disease, and other CVD diseases is anticipated to boost the demand for heart pump devices. For instance, according to data published by British Heart Foundation, in 2022, about 7.6 million individuals in the UK live with heart disease, and each year, around 160,000 people die from CVD and other heart-related conditions in the UK. Moreover, according to WHO data in 2020, coronary heart disease caused 163,905 deaths in Japan, with 121,823 or 11.03% of total deaths were caused due to stroke.
Furthermore, the market is anticipated to grow by increasing support and awareness initiatives for disease awareness. For instance, in January 2022, The School of Medical Research and Technology at IIT Kanpur launched Hridyantra, a challenge-based program. Its objective is to create an advanced artificial heart called a Left Ventricular Assist Device (LVAD) for patients with end-stage heart failure (HF). Hridyantra aims to improve the available treatment options for HF patients. This program is expected to significantly improve the treatment options available for patients with HF, thereby driving market growth.
This product will be delivered within 2 business days.
Furthermore, the market is anticipated to grow by increasing support and awareness initiatives for disease awareness. For instance, in January 2022, The School of Medical Research and Technology at IIT Kanpur launched Hridyantra, a challenge-based program. Its objective is to create an advanced artificial heart called a Left Ventricular Assist Device (LVAD) for patients with end-stage heart failure (HF). Hridyantra aims to improve the available treatment options for HF patients. This program is expected to significantly improve the treatment options available for patients with HF, thereby driving market growth.
Heart Pump Device Market Report Highlights
- Based on type, the implanted heart pump devices segment accounted for the largest revenue share of 69.1% of the market in 2024, due to their ability to assist with pumping blood and serve as a bridge to transplantation or a permanent therapy option for HF patients.
- Based on product, ventricular assist devices (VADs) held the largest market share of 68.5 % in 2024. It is estimated to register the fastest CAGR of 14.8% during the forecast period; owing to the increasing prevalence of HF worldwide, the demand for VADs is anticipated to grow rapidly over the forecast period.
- Based on end-use, the hospital segment dominated the market in 2024, attributed to the high number of surgeries performed in hospitals.
- North America is expected to dominate the market with over 52.59% revenue share in 2024 due to the high prevalence of heart failure, growing aging population, and robust healthcare system.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Heart Pump Device Market Variables, Trends & Scope
Chapter 4. Heart Pump Device Market: Type Estimates & Trend Analysis
Chapter 5. Heart Pump Device Market: Product Estimates & Trend Analysis
Chapter 6. Heart Pump Device Market: End Use Estimates & Trend Analysis
Chapter 7. Heart Pump Device Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies featured in this Heart Pump Device market report include:- Abbott
- ABIOMED (Johnson & Johnson Services, Inc.)
- Getinge
- LivaNova PLC
- Berlin Heart
- Picard Medical, Inc. (SynCardia Systems, LLC)
- Jarvik Heart, Inc.
- BiVACOR Inc.
- Leviticus Cardio
- Teleflex Incorporated.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 120 |
Published | May 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 2.99 Billion |
Forecasted Market Value ( USD | $ 6.39 Billion |
Compound Annual Growth Rate | 13.6% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |